Deng, M., Zhang, M., Xu-Monette, Z. Y., Pham, L. V., Tzankov, A., Visco, C., . . . Young, K. H. (2020). XPO1 expression worsens the prognosis of unfavorable DLBCL that can be effectively targeted by selinexor in the absence of mutant p53. BMC.

Deng, Manman, et al. XPO1 Expression Worsens the Prognosis of Unfavorable DLBCL That Can Be Effectively Targeted By Selinexor in the Absence of Mutant P53. BMC, 2020.

Deng, Manman, et al. XPO1 Expression Worsens the Prognosis of Unfavorable DLBCL That Can Be Effectively Targeted By Selinexor in the Absence of Mutant P53. BMC, 2020.